MedTrace Logo

Impact of a Web-Based Mind-Body Awareness Program on Women Undergoing Infertility Treatment

NCT06585137 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 78

Last updated 2026-07-02

No results posted yet for this study

Summary

The goal of this two-group parallel randomized controlled study is to determine the effect of a web-based mind-body-based awareness program based on Meleis Transition Theory on fertility awareness and readiness levels in women receiving infertility treatment.

Conditions

  • Infertility, Female

Interventions

OTHER

Web-Based Mind-Body Based Awareness Program

The program was developed in accordance with peer-reviewed literature and expert opinions. A nursing approach based on Meleis Transition Theory will include education, mind-body awareness practices, and messages specific to women's health. Participants will take part in a five-session awareness program lasting approximately two weeks. Participants will be asked to complete their first final assessment one day after the oocyte pick-up (OPU) procedure, which corresponds to approximately 8-12 days after ovarian stimulation. No mind-body exercises will be requested between embryo transfer and the day of the pregnancy test. During this period, follow-up between the researcher and participants will continue, and nursing care based on Meleis' theory will be provided. The implementation phase of the study will be completed after the second final assessment conducted one day before the pregnancy test, with at least the minimum required sample size achieved.

Sponsors & Collaborators

  • Assistant Professor Onur İNCE

    collaborator UNKNOWN

  • Associate Professor Dr. Çiğdem YÜCEL ÖZÇIRPAN

    collaborator UNKNOWN

  • Hacettepe University

    lead OTHER

Principal Investigators

  • Onur İNCE, MD · Hacettepe University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
23 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-07-10
Primary Completion
2026-09-20
Completion
2026-11-22

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06585137 on ClinicalTrials.gov